This invention provides 5-HT1F agonists of Formula (I) where A-B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing compounds of Formula (I) as well as methods of treating conditions associated with 5-HT1F activation employing these compounds or compositions.
申请公布号
WO9820875(A1)
申请公布日期
1998.05.22
申请号
WO1997US20630
申请日期
1997.11.13
申请人
ELI LILLY AND COMPANY;FILLA, SANDRA, A.;JOHNSON, KIRK, W.;PHEBUS, LEE, A.;SCHAUS, JOHN, M.
发明人
FILLA, SANDRA, A.;JOHNSON, KIRK, W.;PHEBUS, LEE, A.;SCHAUS, JOHN, M.
